Biocon's biosimilar Insulin Glargine to be listed on Express Scripts' largest formulary in US

New Delhi, Oct 21: Biocon Biologics Ltd (BBL) on Thursday said its interchangeable biosimilar Insulin Glargine, under brand name Semglee, would be listed

Related Keywords

New Delhi ,Delhi ,India ,United States ,America ,Arun Chandavarkar ,Biocon Biologics ,Biocon Biologics Ltd ,Script National Preferred Formulary ,Biocon ,Drug Administration ,Scripts Inc ,Insulin Glargine ,Express Script National Preferred Formulary ,Express Scripts ,Director Arun Chandavarkar ,North America ,